Compare Aegon Ltd. (AEG) vs Amylx Pharmaceuticals Inc (AMLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aegon Ltd. vs Amylx Pharmaceuticals Inc — how do they compare? Aegon Ltd. trades at $9.44 (market cap $14.01B), while Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B). The key difference: Aegon Ltd. is far larger — about 5.3× Amylx Pharmaceuticals Inc's market cap, and Aegon Ltd. pays a 4.94% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AEG | AMLX | |
|---|---|---|
Market Cap | $14.01B | $2.64B |
Sector | Financials | Health |
52-Week High | $9.53 | $24.19 |
52-Week Low | $6.79 | $7.82 |
Enterprise Value | $15.16B | $2.39B |
Dividend Yield | 4.94% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aegon Ltd.
Aegon is a Netherlands-headquartered insurance company with core operations that stretch across the U.S., Netherlands, and United Kingdom. The business also holds peripheral ventures in Spain, Portugal, Brazil, and China.
Read more on AEG →About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →
